Sebi likely to reopen insider trading case against Sun Pharma - Trouble for the company?

Alleged irregularities by the company's promoters and others in raising funds through Foreign Currency Convertible Bonds (FCCBs) may also be investigated by the market regulator.

from India Infoline News Service https://ift.tt/2RAfQ4c